Riluzole Administration in Postnatal Mice
Corresponding Organization :
Other organizations : National Center of Neurology and Psychiatry, Keio University, Tohoku University, Health Sciences University of Hokkaido, Hokkaido University, National Institutes of Natural Sciences, Nagoya City University, RIKEN Center for Brain Science, Kyoto University, Toho University, Fujita Health University, University of Yamanashi
Variable analysis
- Riluzole (13 mg/kg/day)
- Vehicle (saline solution)
- Not explicitly mentioned
- Riluzole dissolved in 10% (2-Hydroxypropyl)-β-cyclodextrin solution and diluted with normal saline to a final experimental concentration (1.3 mg/ml)
- Riluzole or vehicle administered intraperitoneally from P15 to P29 once a day
- Positive control: Riluzole (13 mg/kg/day)
- Negative control: Vehicle (saline solution)
Annotations
Based on most similar protocols
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!